Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savino Bruno

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Optimal management of patients with chronic hepatitis C and comorbiditiesVincenzo Boccaccio, Savino Bruno
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2012
Futility of antiviral treatments for hepatitis C: an evolving concept entering the direct antiviral agents eraSavino Bruno, Alessandra Mangia
Annals of Hepatology|July 16, 2008
The natural course of HCV infection and the need for treatmentSavino Bruno, Corinna Facciotto
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Management of HCV patients with cirrhosis with direct acting antiviralsVincenzo Boccaccio, Savino Bruno
Journal of Hepatology|February 9, 2010
Is response to antiviral treatment influenced by hepatitis B virus genotype?Sara Raimondi, Patrick Maisonneuve, Savino Bruno, et al.
Journal of Hepatology|April 28, 2009
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysisSara Raimondi, Savino Bruno, Mario U Mondelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Is the benefit of treating patients with cirrhosis proven?Savino Bruno, Vincenzo Boccaccio, Maria Luisa Russo, et al.
Expert Review of Clinical Pharmacology|October 6, 2015
Treatment discontinuation with peg-interferon: what to considerVincenzo Boccaccio, Maria Luisa Russo, Marco Carbone, et al.
Hepatic Medicine : Evidence and Research|December 25, 2013
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virusSavino Bruno, Daniela Savojardo, Piero L Almasio, et al.
International Journal of Hepatology|December 14, 2011
The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infectionMarcello Persico, Savino Bruno, Andrea Costantino, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Optimal management of patients with chronic hepatitis C and comorbiditiesVincenzo Boccaccio, Savino Bruno
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2012
Futility of antiviral treatments for hepatitis C: an evolving concept entering the direct antiviral agents eraSavino Bruno, Alessandra Mangia
Annals of Hepatology|July 16, 2008
The natural course of HCV infection and the need for treatmentSavino Bruno, Corinna Facciotto
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Management of HCV patients with cirrhosis with direct acting antiviralsVincenzo Boccaccio, Savino Bruno
Journal of Hepatology|February 9, 2010
Is response to antiviral treatment influenced by hepatitis B virus genotype?Sara Raimondi, Patrick Maisonneuve, Savino Bruno, et al.
Journal of Hepatology|April 28, 2009
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysisSara Raimondi, Savino Bruno, Mario U Mondelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Is the benefit of treating patients with cirrhosis proven?Savino Bruno, Vincenzo Boccaccio, Maria Luisa Russo, et al.
Expert Review of Clinical Pharmacology|October 6, 2015
Treatment discontinuation with peg-interferon: what to considerVincenzo Boccaccio, Maria Luisa Russo, Marco Carbone, et al.
Hepatic Medicine : Evidence and Research|December 25, 2013
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virusSavino Bruno, Daniela Savojardo, Piero L Almasio, et al.
International Journal of Hepatology|December 14, 2011
The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infectionMarcello Persico, Savino Bruno, Andrea Costantino, et al.
Pageof 7